![Erythromycin EP Impurity C ; Erythromycin E ; (2S,4aR,4′R,5′S,6′S,7R,8S,9R,10R,12R,14R,15R,16S)-7-Ethyl-5′,8,9,14-tetrahydroxy-4′-methoxy-4′,6′,8,10,12,14,16-heptamethyl-15-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]hexadecahydrospiro[5H,11H-1,3-dioxino[5,4c]oxacyclotetradecin-2,2′-pyrane]-5,11-dione](https://drjcrbio.com/wp-content/uploads/e-4.png)
Erythromycin EP Impurity C ; Erythromycin E ; (2S,4aR,4′R,5′S,6′S,7R,8S,9R,10R,12R,14R,15R,16S)-7-Ethyl-5′,8,9,14-tetrahydroxy-4′-methoxy-4′,6′,8,10,12,14,16-heptamethyl-15-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]hexadecahydrospiro[5H,11H-1,3-dioxino[5,4c]oxacyclotetradecin-2,2′-pyrane]-5,11-dione
Description
| Code: JCERM-04 |
| CAS: NA |
| Chemical Formula: C37H65NO14 |
| Molecular Weight: 747.91 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Erythromycin EP Impurity C ; Erythromycin E ; (2S,4aR,4′R,5′S,6′S,7R,8S,9R,10R,12R,14R,15R,16S)-7-Ethyl-5′,8,9,14-tetrahydroxy-4′-methoxy-4′,6′,8,10,12,14,16-heptamethyl-15-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]hexadecahydrospiro[5H,11H-1,3-dioxino[5,4c]oxacyclotetradecin-2,2′-pyrane]-5,11-dione is useful as reference Impurity standard. |
